Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2024-09-13 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges (NSE and BSE) regarding a regulatory matter under SEBI Listing Obligations and Disclosure Requirements (Regulation 30). It discusses a Show Cause Notice (SCN) received from a tax authority and the subsequent order dropping the proceedings. The document includes details of the regulatory action and its impact, which is typical of a regulatory announcement. The document length is 3486 characters, which is relatively short and does not contain financial statements or detailed financial analysis. It is not an annual or interim report, audit report, earnings release, or any other detailed financial report. Instead, it is a regulatory disclosure about a legal/tax proceeding resolution. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-09-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of an upcoming investor conference. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 2015, indicating it is a regulatory announcement. The content is about notifying the schedule of an investor conference, not the conference transcript or any financial report. The document is short (1583 characters) and serves as an announcement rather than a detailed report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-09-12 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of newspaper advertisements about the 77th Annual General Meeting (AGM) and e-voting information. It references compliance with SEBI Listing Regulations and the Companies Act related to general meetings. The document is short (1950 characters) and primarily serves to inform about the advertisement publication rather than containing AGM materials or detailed reports. Therefore, it is an announcement related to AGM information, specifically about the advertisement and e-voting details for the AGM, not the AGM materials themselves. This fits best under Regulatory Filings (RNS) as it is a compliance announcement and does not contain AGM presentations or detailed report content.
2024-09-03 English
Updates
Annual Report Classification · 100% confidence The document is a detailed communication addressed to stock exchanges regarding the Notice of the 77th Annual General Meeting (AGM) and the Annual Report for the financial year 2023-2024. It includes extensive content typical of an Annual Report such as corporate information, board of directors, auditors, financial highlights, management messages, awards, and a detailed table of contents listing financial statements, auditor reports, and management discussion and analysis. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of comprehensive financial data, management commentary, and auditor reports confirms this is the full Annual Report. Therefore, the correct classification is Annual Report (10-K). FY 2024
2024-09-02 English
Book Closure
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the intimation of cut-off date for e-voting, book closure, and record date related to the final dividend and the upcoming Annual General Meeting (AGM). It references the dividend recommended by the Board and the schedule for the AGM, including voting procedures. The document does not contain financial statements or detailed financial data but serves as an official announcement related to shareholder voting and dividend payment dates. It is not the AGM materials themselves, nor a full annual report or earnings release. The content fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it informs shareholders about voting eligibility and record dates for dividend entitlement and AGM participation.
2024-08-30 English
Record Date
Notice of Dividend Amount Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the intimation of cut-off date for e-voting, book closure, and record date related to the final dividend for the financial year ended 31st March 2024. It references the upcoming Annual General Meeting (AGM) scheduled for 26th September 2024 and details administrative dates for dividend payment and voting eligibility. The document does not contain financial statements or detailed financial data but serves as an official announcement related to shareholder voting and dividend record dates. It is not the AGM materials themselves, nor a full annual report or earnings release. Given the nature of the content—announcement of record date, book closure, and e-voting cut-off related to dividend and AGM—the document fits best under Notice of Dividend Amount (DIV) category, as it informs shareholders about dividend payment timelines and related procedural dates.
2024-08-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.